These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4671348)

  • 1. [Use of rifampicin in tuberculous patients with liver diseases].
    Pozzi E; Menghini P
    G Ital Chemioter; 1972 Jul; 19(3):63-8. PubMed ID: 4671348
    [No Abstract]   [Full Text] [Related]  

  • 2. [The optimal use of rifampicin in the polychemotherapy of pulmonary tuberculosis, with special reference to its liver-damaging potential: considerations and case studies].
    Salvati F; Mugnaini L; Altieri AM; De Marinis F
    Clin Ter; 1979 Jan; 88(1):45-50. PubMed ID: 436377
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tolerance of rifampicin in long-term treatment of patients with pulmonary tuberculosis].
    Fokina LV; Vusygina RN; Antosik OD
    Probl Tuberk; 1976 Feb; (21):34-9. PubMed ID: 1264980
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatic dysfunction in tuberculous patients treated with rifampicin and isoniazid.
    Burke M; Logan J
    Ir Med J; 1979 Oct; 72(10):430-4. PubMed ID: 500344
    [No Abstract]   [Full Text] [Related]  

  • 5. [Rifampicin. Study of its antitubercular effect and its hepatic tolerance in 200 patients].
    Macquet V; Lafitte P; Rogeaux Y
    Lille Med; 1972 May; 17(5):755-61. PubMed ID: 5056293
    [No Abstract]   [Full Text] [Related]  

  • 6. [The hepatotoxicity of rifampicin and its modification through "essential" choline phospholipids].
    Kuntz HD; Rausch V; Bammel E
    Med Welt; 1978 Mar; 29(11):452-4. PubMed ID: 651600
    [No Abstract]   [Full Text] [Related]  

  • 7. [Side effects in strictly supervised treatment with rifampicin and ethambutol].
    Năstase M; Năstase R; Brener E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):241-3. PubMed ID: 174182
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of rifampicin in tuberculosis].
    Rabukhin AE
    Klin Med (Mosk); 1973 Mar; 51(3):70-6. PubMed ID: 4755485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study of adverse reactions in pulmonary tuberculosis patients treated with rifampicin].
    Anastasatu C; Dinulică E; Algeorge G; Cărpinişan L; Varga E; Rudescu D
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(4):213-9. PubMed ID: 174177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of isoniazid in hepatotoxicity with the INH-rifampicin combination in tuberculosis in children].
    Dieu MJ
    J Med Lyon; 1972 Oct; 53(234):1323-4 passim. PubMed ID: 4539047
    [No Abstract]   [Full Text] [Related]  

  • 11. Side effects of rifampicin. A clinical study.
    Mattson K
    Scand J Respir Dis Suppl; 1973; 82():1-52. PubMed ID: 4518740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin and liver damage].
    Sehm G
    Prax Pneumol; 1970 Jul; 24(7):439-42. PubMed ID: 5433240
    [No Abstract]   [Full Text] [Related]  

  • 13. [A case of icterus in the course of treatment with rifampicin. Histological records].
    Laroche C; Caquet R; Desche-Labarthe S; Fraisse B; Lemaigre G
    Ann Med Interne (Paris); 1971 Nov; 122(11):1119-22. PubMed ID: 5150312
    [No Abstract]   [Full Text] [Related]  

  • 14. [A hepatitis epidemic with 5 cases of fatal acute atrophy in patients under polychemiotherapy including rifampicin].
    Caroli J; Opolon P; Lechevallier R; Hadchouel P; Thomas M
    Rev Med Chir Mal Foie; 1971; 46(3):123-35. PubMed ID: 5110423
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin in the treatment of active pulmonary tuberculosis. Controlled trial of isoniazid-rifampicin-thiocarlide versus isoniazid-streptomycin-thiocarlide in untreated tuberculosis. Treatment of relapses with the combination rifampicin-ethambutol-thiocarlide].
    Chioléro R
    Schweiz Med Wochenschr; 1974 Mar; 104(10):356-64. PubMed ID: 4206521
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rifampicin in the retreatment of severe cavitary pulmonary tuberculosis. 2. Drug resistance, drug concentration in blood and side effects].
    Baba H; Takahashi R; Azuma Y
    Kekkaku; 1971 Dec; 46(12):481-9. PubMed ID: 5004601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Adverse reactions to antitubercular treatment with rifampin (Considerations on 14 cases].
    Didilescu C; Rădulescu G; Filip G; Constantinescu I; Măgălie D; Satcău C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(3):177-80. PubMed ID: 229543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatotoxic side-effects of rifampicin; a comparative clinical study (author's transl)].
    Kuntz HD; Rausch V
    Prax Klin Pneumol; 1977 Nov; 31(11):925-32. PubMed ID: 928291
    [No Abstract]   [Full Text] [Related]  

  • 19. Predisposing factors in hepatitis induced by isoniazid-rifampin treatment of tuberculosis.
    Grönhagen-Riska C; Hellstrom PE; Fröseth B
    Am Rev Respir Dis; 1978 Sep; 118(3):461-6. PubMed ID: 707874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The liver and rifampicin].
    Piéron R; Marien C; Jagueux M
    Cah Med; 1973 Jun; 14(6):447-51. PubMed ID: 4766668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.